EORTC-24851-HNCG

PHASE II STUDY OF 4'-EPIDoxorubicin IN RECURRENT OR METASTATIC ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK.
Trial StatusAll trial activities ended
DatesDate of activation: 15-Jan-86
Closed on : 15-Feb-89
Data management at EORTCFull
Phase2
Randomized trial
Type-
Targeted Sample size14
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT number
EudraCT